01Table 1: Science & Market
Table Host: Marta Winiarska
When is scientific excellence not enough?
29.10.2026 · Warsaw · Hosted at Forum MedTech. AstraZeneca
From Lab to Market
How to evaluate biotech and healthcare projects?
Free to attend, seats are limited.
“Which one of these forty projects in my pipeline is actually ready?”
Every investor, TTO, and accelerator answers this every week. Almost none answer it the same way twice. Ready means one thing: able to absorb capital or reach the next value-inflection milestone. Not promising. Not interesting. Ready.
When
Thursday, 29.10.2026
13:00 – 17:00
Where
Forum AstraZeneca
ul. Postępu 14, 02-676 Warsaw
Who it's for
Founders, scientists & innovators, VCs & angels, tech transfer officers, pharma BD, venture builders.
Why this meetup
Breakthrough science doesn't only die from bad biology.
It dies in the gap between how scientists work and how capital decides. On October 29th we're bringing every side of that gap into one room, so next time someone asks “which one is ready?”, there's a better answer.
Panel discussion
A lightning panel of investors, founders, and TTOs on what “ready” actually means.
Roundtables
World Café format: five tables, five hard questions, every seat rotates.
Networking
Open coffee at the start, open floor at the end, no agenda required.
Who's in the room
FoundersVCs & AngelsTech Transfer OfficersPharma BDVenture BuildersPublic FundersScientists & Researchers
Agenda
Three and a half hours, no filler.
13:00 – 13:15
Networking & Welcome Coffee
13:15 – 13:30
Opening Remarks
Why do good innovations fail despite strong science, funding, and market need?
13:30 – 14:15
Lightning Panel Discussion
Which one is actually ready? What does a good project look like?
14:20 – 15:35
Roundtables / World Café Format
Five parallel tables rotate through the questions that decide whether a project is ready.
15:40 – 16:20
Reporting Back & Interactive Session
“Ready means…” — each table shares its key insight and biggest disagreement.
16:30 – 17:00
Networking
Speakers & Panelists
Every side of the table.
Magdalena Marciniak
I&I Bio Fund
WeBeam
Klaudia Kożusznik
Foundation for Polish Science
WeBeam
Piotr Kędra
Investment Director
PFR Ventures
Karolina Jarosińska
Managing Director
ExecMind
Michał Jeska
Innovation Program Manager
i&i Prague
Igors Berkovics
Co-Founder
BioCatalyst
Dorota Gierej-Czerkies, PhD
CEO, PeptAid
Instytut Nencki
Marta Winiarska
CEO
Bioinmed
Tomasz Nocuń
CEO
FamiCordTx
To be announced
What the panel will dig into
- Which one is actually ready? What does a good project look like?
- Why do promising projects fail?
- What do you evaluate first?
- What are your deal breakers?
- What do others misunderstand about your role in a process?
- How do you value a project, and what does your decision process look like?
Roundtables · World Café format
Five tables. Five questions that decide if a project is ready.
Every seat rotates through the room, so by 15:35 you've heard every angle, not just the one you came in with.
0102
Table 2: Investment Readiness
Table Host: to be announced
What evidence would make you invest tomorrow in a healthcare project?
03Table 3: Regulatory Risk
Table Host: Tomasz Nocuń
At what point should regulatory strategy become part of evaluation?
04Table 4: Execution Capability
Table Host: Karolina Jarosińska
How do you assess whether a team can actually deliver?
05Table 5: Biases in Innovation Evaluation
Table Host: Igors Berkovics
What assumptions most often lead us to reject good projects?
Host & partners
Hosted at Forum AstraZeneca, built with the ecosystem.
Venue host
Strategic Partner & Organizer
Partners
Organizers
Questions before you register?
Save your seat
Register for From Lab to Market
Thursday, October 29th, 13:00–17:00, at Forum AstraZeneca, Warsaw. Free to attend, seats are limited.
Reserve my seat →